Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026)
Verano Holdings' (VRNO) quarterly Depreciation and Depletion came in at $4.8 million in Q1 2026, down 5.33% year-on-year from $5.1 million in Q1 2025, and down 89.04% on a QoQ basis from $44.2 million in Q4 2025.
Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Depreciation and Depletion data on file, last reported at $4.8 million in Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 5.33% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $63.8 million, a 5.39% increase from a year earlier, with the FY2025 full-year figure at $59.2 million, up 8.99% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $4.8 million, down from $44.2 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for VRNO reached as high as $44.2 million in Q4 2025 and fell as low as -$5.9 million in Q3 2022.
- Historically, Depreciation and Depletion has averaged $11.7 million across 5 years, with a median of $5.1 million in 2025.
- Across the five-year window, Depreciation and Depletion slumped 403.62% in 2022 and soared 211.01% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $12.3 million in 2022, then surged by 211.01% to $38.2 million in 2023, then increased by 9.43% to $41.8 million in 2024, then rose by 5.96% to $44.2 million in 2025, then tumbled by 89.04% to $4.8 million in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $4.8 million in Q1 2026, $44.2 million in Q4 2025, and $4.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.85 Mn |
| Mar 31, 2026 | 4.85 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Sep 30, 2025 | 4.90 Mn |
| Sep 30, 2025 | 4.90 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 41.75 Mn |
| Dec 31, 2024 | 41.75 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 38.16 Mn |
| Dec 31, 2023 | 38.16 Mn |